English

ALPHARMA INC

EDGAR

Quarterly report (10-Q) · filed 2008-10-29

97 filing records in this dataset, filed from 1994-05-12 to 2008-10-29. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

176 million USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 175698000 USD Source

Operating margin

5.55%

2008-09-30 · %

Exact inputs and evidence

Operating Income: 9744000 USD Source
Revenue: 175698000 USD Source

Operating cash flow

-237 thousand USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -36267000 USD Source
Operating Cash Flow: -36030000 USD Source

Free cash flow

-2.69 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -36267000 USD Source
Operating Cash Flow: -36030000 USD Source
Capital Expenditure: 18583000 USD Source
Capital Expenditure: 16126000 USD Source

Cash and cash equivalents: 571 million USD 2008-09-30 Source
Exact value

571024000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

114 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Net income: -13581000 USD · 2007-01-01 – 2007-12-31 Source
Net income: 40047000 USD · 2007-01-01 – 2007-09-30 Source
Net income: 171112000 USD · 2008-01-01 – 2008-03-31 Source
Net income: -7382000 USD · 2008-04-01 – 2008-06-30 Source
Net income: 4120000 USD · 2008-07-01 – 2008-09-30 Source

Operating cash flow

-55.3 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Operating cash flow: 46991000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: 66024000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -17830000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -36030000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -17830000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -36267000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -36030000 USD · 2008-01-01 – 2008-06-30 Source

Capital expenditure

37.3 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Capital expenditure: 60499000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 41793000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 9385000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 16126000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 9385000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 18583000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 16126000 USD · 2008-01-01 – 2008-06-30 Source

Free cash flow

-92.6 million USD

2007-10-01 – 2008-09-30

Exact inputs and evidence

Operating cash flow: 46991000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: 66024000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -17830000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -36030000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -17830000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: -36267000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -36030000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 60499000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 41793000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 9385000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 16126000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 9385000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 18583000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 16126000 USD · 2008-01-01 – 2008-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-10-29.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2007-12-31
Operating income: 11 of 11 periods available· newest 2007-12-31
Net income: 11 of 11 periods available· newest 2007-12-31
Operating cash flow: 11 of 11 periods available· newest 2007-12-31
Capital expenditure: 11 of 11 periods available· newest 2007-12-31
Total assets: 11 of 11 periods available· newest 2007-12-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2007-12-31
Current liabilities: 11 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+10.5%

Prior period

USD 653.83 million

2006-01-01 – 2006-12-31
Current period

USD 722.43 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

722425000 − 653828000 = 68597000 USD

653828000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
722425000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ALPHARMA INC · 2007-12-31 ALPHARMA INC (edgar:730469) Year-over-year change in Revenue: 68597000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 722425000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#4109 Input fundies:Revenue: 653828000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#4109
The citation records this snapshot. The page link may show a newer release later.
Net income
-116.5%

Prior period

USD 82.54 million

2006-01-01 – 2006-12-31
Current period

−USD 13.58 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-13581000 − 82544000 = -96125000 USD

82544000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-13581000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ALPHARMA INC · 2007-12-31 ALPHARMA INC (edgar:730469) Year-over-year change in Net income: -96125000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13581000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5432 Input fundies:NetIncome: 82544000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5432
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+9.5%

Prior period

USD 42.93 million

2006-01-01 – 2006-12-31
Current period

USD 46.99 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

46991000 − 42933000 = 4058000 USD

42933000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
46991000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ALPHARMA INC · 2007-12-31 ALPHARMA INC (edgar:730469) Year-over-year change in Operating cash flow: 4058000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 46991000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5671 Input fundies:OperatingCashFlow: 42933000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5671
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+67.3%

Prior period

USD 36.17 million

2006-01-01 – 2006-12-31
Current period

USD 60.5 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

60499000 − 36171000 = 24328000 USD

36171000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
60499000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ALPHARMA INC · 2007-12-31 ALPHARMA INC (edgar:730469) Year-over-year change in Capital expenditure: 24328000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 60499000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5710 Input fundies:CapitalExpenditure: 36171000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5710
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 722.43 million 100% of revenue
Cost of revenue USD 313.05 million 43% of revenue
Operating expenses USD 412.2 million 57% of revenue
Operating income USD 706,000 0.1% of revenue
Tax, interest and other Derived USD 14.29 million 2% of revenue
Net income −USD 13.58 million −1.9% of revenue

Cash

Operating cash flow USD 46.99 million 6.5% of revenue
Capital expenditure USD 60.5 million 8.4% of revenue
Free cash flow Derived −USD 13.51 million −1.9% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 89%
1999 Net income was higher than operating income, so the split is not drawn.
2000 86%
2001 Net loss: net income was −3.9% of revenue.
2002 Operating loss: operating costs were 102% of revenue.
2003 11%86%
2004 Net loss: net income was −61% of revenue.
2005 Net income was higher than operating income, so the split is not drawn.
2006 13%85%
2007 Net loss: net income was −1.9% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	604584000	539588000 Derived	64996000	40785000 Derived	24211000	26692000 Derived	Source 1998-01-01 – 1998-12-31: 604584000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 64996000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 24211000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 58070000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 31378000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	732443000	732347648 Derived	95352	-29896648 Derived	29992000	37873000 Derived	Source 1999-01-01 – 1999-12-31: 732443000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 95352 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 29992000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 71608000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 33735000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	892977000	768337000 Derived	124640000	69775000 Derived	54865000	-38964000 Derived	Source 2000-01-01 – 2000-12-31: 892977000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: 124640000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: 54865000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 33124000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 72088000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	969286000	943306000 Derived	25980000	63682000 Derived	-37702000	34137000 Derived	Source 2001-01-01 – 2001-12-31: 969286000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: 25980000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -37702000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 119384000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 85247000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	1230762000	1254973000 Derived	-24211000	75450000 Derived	-99661000	87810000 Derived	Source 2002-01-01 – 2002-12-31: 1230762000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -24211000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -99661000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 162200000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 74390000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	479467000	410605000 Derived	68862000	55029000 Derived	13833000	114381000 Derived	Source 2003-01-01 – 2003-12-31: 479467000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 68862000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 13833000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 157000000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 42619000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	513329000	450307000 Derived	63022000	377759000 Derived	-314737000	136856000 Derived	Source 2004-01-01 – 2004-12-31: 513329000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 63022000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -314737000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 186162000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 49306000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	553617000	458806000 Derived	94811000	-38958000 Derived	133769000	208342000 Derived	Source 2005-01-01 – 2005-12-31: 553617000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 94811000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 133769000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 247281000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 38939000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	653828000	558228000 Derived	95600000	13056000 Derived	82544000	6762000 Derived	Source 2006-01-01 – 2006-12-31: 653828000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 95600000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 82544000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 42933000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 36171000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	722425000	721719000 Derived	706000	14287000 Derived	-13581000	-13508000 Derived	Source 2007-01-01 – 2007-12-31: 722425000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 706000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -13581000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 46991000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 60499000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 722.4M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	604584000	Revenue: 604584000 Open source
19991999-12-31	Revenue	732443000	Revenue: 732443000 Open source
20002000-12-31	Revenue	892977000	Revenue: 892977000 Open source
20012001-12-31	Revenue	969286000	Revenue: 969286000 Open source
20022002-12-31	Revenue	1230762000	Revenue: 1230762000 Open source
20032003-12-31	Revenue	479467000	Revenue: 479467000 Open source
20042004-12-31	Revenue	513329000	Revenue: 513329000 Open source
20052005-12-31	Revenue	553617000	Revenue: 553617000 Open source
20062006-12-31	Revenue	653828000	Revenue: 653828000 Open source
20072007-12-31	Revenue	722425000	Revenue: 722425000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

10.5% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	20.8%	Revenue: 604584000 Open source Revenue: 500288000 Open source
19991999-12-31	Year over year	21.1%	Revenue: 732443000 Open source Revenue: 604584000 Open source
20002000-12-31	Year over year	21.9%	Revenue: 892977000 Open source Revenue: 732443000 Open source
20012001-12-31	Year over year	8.5%	Revenue: 969286000 Open source Revenue: 892977000 Open source
20022002-12-31	Year over year	27%	Revenue: 1230762000 Open source Revenue: 969286000 Open source
20032003-12-31	Year over year	-61%	Revenue: 479467000 Open source Revenue: 1230762000 Open source
20042004-12-31	Year over year	7.1%	Revenue: 513329000 Open source Revenue: 479467000 Open source
20052005-12-31	Year over year	7.8%	Revenue: 553617000 Open source Revenue: 513329000 Open source
20062006-12-31	Year over year	18.1%	Revenue: 653828000 Open source Revenue: 553617000 Open source
20072007-12-31	Year over year	10.5%	Revenue: 722425000 Open source Revenue: 653828000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0.1% 2007

Net margin -1.9% 2007

Free cash flow margin -1.9% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	10.8%	Operating Income: 64996000 Open source Revenue: 604584000 Open source
19991999-12-31	Operating margin	0%	Operating Income: 95352 Open source Revenue: 732443000 Open source
20002000-12-31	Operating margin	14%	Operating Income: 124640000 Open source Revenue: 892977000 Open source
20012001-12-31	Operating margin	2.7%	Operating Income: 25980000 Open source Revenue: 969286000 Open source
20022002-12-31	Operating margin	-2%	Operating Income: -24211000 Open source Revenue: 1230762000 Open source
20032003-12-31	Operating margin	14.4%	Operating Income: 68862000 Open source Revenue: 479467000 Open source
20042004-12-31	Operating margin	12.3%	Operating Income: 63022000 Open source Revenue: 513329000 Open source
20052005-12-31	Operating margin	17.1%	Operating Income: 94811000 Open source Revenue: 553617000 Open source
20062006-12-31	Operating margin	14.6%	Operating Income: 95600000 Open source Revenue: 653828000 Open source
20072007-12-31	Operating margin	0.1%	Operating Income: 706000 Open source Revenue: 722425000 Open source
19981998-12-31	Net margin	4%	Net Income: 24211000 Open source Revenue: 604584000 Open source
19991999-12-31	Net margin	4.1%	Net Income: 29992000 Open source Revenue: 732443000 Open source
20002000-12-31	Net margin	6.1%	Net Income: 54865000 Open source Revenue: 892977000 Open source
20012001-12-31	Net margin	-3.9%	Net Income: -37702000 Open source Revenue: 969286000 Open source
20022002-12-31	Net margin	-8.1%	Net Income: -99661000 Open source Revenue: 1230762000 Open source
20032003-12-31	Net margin	2.9%	Net Income: 13833000 Open source Revenue: 479467000 Open source
20042004-12-31	Net margin	-61.3%	Net Income: -314737000 Open source Revenue: 513329000 Open source
20052005-12-31	Net margin	24.2%	Net Income: 133769000 Open source Revenue: 553617000 Open source
20062006-12-31	Net margin	12.6%	Net Income: 82544000 Open source Revenue: 653828000 Open source
20072007-12-31	Net margin	-1.9%	Net Income: -13581000 Open source Revenue: 722425000 Open source
19981998-12-31	Free cash flow margin	4.4%	Revenue: 604584000 Open source Operating Cash Flow: 58070000 Open source Capital Expenditure: 31378000 Open source
19991999-12-31	Free cash flow margin	5.2%	Revenue: 732443000 Open source Operating Cash Flow: 71608000 Open source Capital Expenditure: 33735000 Open source
20002000-12-31	Free cash flow margin	-4.4%	Revenue: 892977000 Open source Operating Cash Flow: 33124000 Open source Capital Expenditure: 72088000 Open source
20012001-12-31	Free cash flow margin	3.5%	Revenue: 969286000 Open source Operating Cash Flow: 119384000 Open source Capital Expenditure: 85247000 Open source
20022002-12-31	Free cash flow margin	7.1%	Revenue: 1230762000 Open source Operating Cash Flow: 162200000 Open source Capital Expenditure: 74390000 Open source
20032003-12-31	Free cash flow margin	23.9%	Revenue: 479467000 Open source Operating Cash Flow: 157000000 Open source Capital Expenditure: 42619000 Open source
20042004-12-31	Free cash flow margin	26.7%	Revenue: 513329000 Open source Operating Cash Flow: 186162000 Open source Capital Expenditure: 49306000 Open source
20052005-12-31	Free cash flow margin	37.6%	Revenue: 553617000 Open source Operating Cash Flow: 247281000 Open source Capital Expenditure: 38939000 Open source
20062006-12-31	Free cash flow margin	1%	Revenue: 653828000 Open source Operating Cash Flow: 42933000 Open source Capital Expenditure: 36171000 Open source
20072007-12-31	Free cash flow margin	-1.9%	Revenue: 722425000 Open source Operating Cash Flow: 46991000 Open source Capital Expenditure: 60499000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 47M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	58070000	Operating Cash Flow: 58070000 Open source
19991999-12-31	Operating cash flow	71608000	Operating Cash Flow: 71608000 Open source
20002000-12-31	Operating cash flow	33124000	Operating Cash Flow: 33124000 Open source
20012001-12-31	Operating cash flow	119384000	Operating Cash Flow: 119384000 Open source
20022002-12-31	Operating cash flow	162200000	Operating Cash Flow: 162200000 Open source
20032003-12-31	Operating cash flow	157000000	Operating Cash Flow: 157000000 Open source
20042004-12-31	Operating cash flow	186162000	Operating Cash Flow: 186162000 Open source
20052005-12-31	Operating cash flow	247281000	Operating Cash Flow: 247281000 Open source
20062006-12-31	Operating cash flow	42933000	Operating Cash Flow: 42933000 Open source
20072007-12-31	Operating cash flow	46991000	Operating Cash Flow: 46991000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -13.5M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	26692000	Operating Cash Flow: 58070000 Open source Capital Expenditure: 31378000 Open source
19991999-12-31	Free cash flow	37873000	Operating Cash Flow: 71608000 Open source Capital Expenditure: 33735000 Open source
20002000-12-31	Free cash flow	-38964000	Operating Cash Flow: 33124000 Open source Capital Expenditure: 72088000 Open source
20012001-12-31	Free cash flow	34137000	Operating Cash Flow: 119384000 Open source Capital Expenditure: 85247000 Open source
20022002-12-31	Free cash flow	87810000	Operating Cash Flow: 162200000 Open source Capital Expenditure: 74390000 Open source
20032003-12-31	Free cash flow	114381000	Operating Cash Flow: 157000000 Open source Capital Expenditure: 42619000 Open source
20042004-12-31	Free cash flow	136856000	Operating Cash Flow: 186162000 Open source Capital Expenditure: 49306000 Open source
20052005-12-31	Free cash flow	208342000	Operating Cash Flow: 247281000 Open source Capital Expenditure: 38939000 Open source
20062006-12-31	Free cash flow	6762000	Operating Cash Flow: 42933000 Open source Capital Expenditure: 36171000 Open source
20072007-12-31	Free cash flow	-13508000	Operating Cash Flow: 46991000 Open source Capital Expenditure: 60499000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	Total Assets: 908936000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 1151856000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 1610435000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 2390008000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 2296924000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 2329268000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 2039612000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 1623383000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 927239000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 1296350000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.83× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Current assets / current liabilities	1.97×	Current Assets: 335484000 Open source Current Liabilities: 170437000 Open source
19991999-12-31	Current assets / current liabilities	2.27×	Current Assets: 373462000 Open source Current Liabilities: 164276000 Open source
20002000-12-31	Current assets / current liabilities	2.91×	Current Assets: 600418000 Open source Current Liabilities: 206438000 Open source
20012001-12-31	Current assets / current liabilities	1.92×	Current Assets: 662521000 Open source Current Liabilities: 345015000 Open source
20022002-12-31	Current assets / current liabilities	1.77×	Current Assets: 671429000 Open source Current Liabilities: 378601000 Open source
20032003-12-31	Current assets / current liabilities	0.75×	Current Assets: 692991000 Open source Current Liabilities: 926180000 Open source
20042004-12-31	Current assets / current liabilities	0.65×	Current Assets: 672072000 Open source Current Liabilities: 1040406000 Open source
20052005-12-31	Current assets / current liabilities	1.56×	Current Assets: 1037047000 Open source Current Liabilities: 665257000 Open source
20062006-12-31	Current assets / current liabilities	2.27×	Current Assets: 353541000 Open source Current Liabilities: 155573000 Open source
20072007-12-31	Current assets / current liabilities	2.83×	Current Assets: 583887000 Open source Current Liabilities: 206560000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	USD 24.21 million Exact value Exact value: 24211000 USD 1998-01-01 – 1998-12-31: 24211000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 1998-12-31 ALPHARMA INC (edgar:730469) Net Income: 24211000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 24211000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-01-500003.txt#7047 The citation records this snapshot. The page link may show a newer release later.	USD 58.07 million Exact value Exact value: 58070000 USD 1998-01-01 – 1998-12-31: 58070000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 1998-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 58070000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 58070000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-01-500003.txt#7197 The citation records this snapshot. The page link may show a newer release later.	USD 31.38 million Exact value Exact value: 31378000 USD 1998-01-01 – 1998-12-31: 31378000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 1998-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 31378000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 31378000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-01-500003.txt#7226 The citation records this snapshot. The page link may show a newer release later.	USD 26.69 million Calculation and evidence 58070000 − 31378000 USD Exact free cash flow: 26692000 USD 1998-01-01 – 1998-12-31: 58070000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 31378000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 1998-12-31 ALPHARMA INC (edgar:730469) Free cash flow: 26692000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 58070000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-01-500003.txt#7197 Input fundies:CapitalExpenditure: 31378000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-01-500003.txt#7226 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 29.99 million Exact value Exact value: 29992000 USD 1999-01-01 – 1999-12-31: 29992000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 1999-12-31 ALPHARMA INC (edgar:730469) Net Income: 29992000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 29992000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#4855 The citation records this snapshot. The page link may show a newer release later.	USD 71.61 million Exact value Exact value: 71608000 USD 1999-01-01 – 1999-12-31: 71608000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 1999-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 71608000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 71608000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#5029 The citation records this snapshot. The page link may show a newer release later.	USD 33.74 million Exact value Exact value: 33735000 USD 1999-01-01 – 1999-12-31: 33735000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 1999-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 33735000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33735000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#5058 The citation records this snapshot. The page link may show a newer release later.	USD 37.87 million Calculation and evidence 71608000 − 33735000 USD Exact free cash flow: 37873000 USD 1999-01-01 – 1999-12-31: 71608000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 33735000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 1999-12-31 ALPHARMA INC (edgar:730469) Free cash flow: 37873000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 71608000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#5029 Input fundies:CapitalExpenditure: 33735000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#5058 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	USD 54.87 million Exact value Exact value: 54865000 USD 2000-01-01 – 2000-12-31: 54865000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 2000-12-31 ALPHARMA INC (edgar:730469) Net Income: 54865000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 54865000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-04-000019.txt#4041 The citation records this snapshot. The page link may show a newer release later.	USD 33.12 million Exact value Exact value: 33124000 USD 2000-01-01 – 2000-12-31: 33124000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 2000-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 33124000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 33124000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#5029 The citation records this snapshot. The page link may show a newer release later.	USD 72.09 million Exact value Exact value: 72088000 USD 2000-01-01 – 2000-12-31: 72088000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 2000-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 72088000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 72088000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#5058 The citation records this snapshot. The page link may show a newer release later.	−USD 38.96 million Calculation and evidence 33124000 − 72088000 USD Exact free cash flow: -38964000 USD 2000-01-01 – 2000-12-31: 33124000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 72088000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 2000-12-31 ALPHARMA INC (edgar:730469) Free cash flow: -38964000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 33124000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#5029 Input fundies:CapitalExpenditure: 72088000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-02-000004.txt#5058 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 37.7 million Exact value Exact value: -37702000 USD 2001-01-01 – 2001-12-31: -37702000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 2001-12-31 ALPHARMA INC (edgar:730469) Net Income: -37702000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -37702000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#5958 The citation records this snapshot. The page link may show a newer release later.	USD 119.38 million Exact value Exact value: 119384000 USD 2001-01-01 – 2001-12-31: 119384000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 2001-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 119384000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 119384000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6154 The citation records this snapshot. The page link may show a newer release later.	USD 85.25 million Exact value Exact value: 85247000 USD 2001-01-01 – 2001-12-31: 85247000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 2001-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 85247000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 85247000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6183 The citation records this snapshot. The page link may show a newer release later.	USD 34.14 million Calculation and evidence 119384000 − 85247000 USD Exact free cash flow: 34137000 USD 2001-01-01 – 2001-12-31: 119384000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 85247000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 2001-12-31 ALPHARMA INC (edgar:730469) Free cash flow: 34137000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 119384000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6154 Input fundies:CapitalExpenditure: 85247000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6183 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 99.66 million Exact value Exact value: -99661000 USD 2002-01-01 – 2002-12-31: -99661000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 2002-12-31 ALPHARMA INC (edgar:730469) Net Income: -99661000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -99661000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000035.txt#5350 The citation records this snapshot. The page link may show a newer release later.	USD 162.2 million Exact value Exact value: 162200000 USD 2002-01-01 – 2002-12-31: 162200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 2002-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 162200000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 162200000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6154 The citation records this snapshot. The page link may show a newer release later.	USD 74.39 million Exact value Exact value: 74390000 USD 2002-01-01 – 2002-12-31: 74390000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 2002-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 74390000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 74390000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6183 The citation records this snapshot. The page link may show a newer release later.	USD 87.81 million Calculation and evidence 162200000 − 74390000 USD Exact free cash flow: 87810000 USD 2002-01-01 – 2002-12-31: 162200000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 74390000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 2002-12-31 ALPHARMA INC (edgar:730469) Free cash flow: 87810000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 162200000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6154 Input fundies:CapitalExpenditure: 74390000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6183 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	USD 13.83 million Exact value Exact value: 13833000 USD 2003-01-01 – 2003-12-31: 13833000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 2003-12-31 ALPHARMA INC (edgar:730469) Net Income: 13833000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 13833000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-06-000027.txt#4381 The citation records this snapshot. The page link may show a newer release later.	USD 157 million Exact value Exact value: 157000000 USD 2003-01-01 – 2003-12-31: 157000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 2003-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 157000000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 157000000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6154 The citation records this snapshot. The page link may show a newer release later.	USD 42.62 million Exact value Exact value: 42619000 USD 2003-01-01 – 2003-12-31: 42619000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 2003-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 42619000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 42619000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6183 The citation records this snapshot. The page link may show a newer release later.	USD 114.38 million Calculation and evidence 157000000 − 42619000 USD Exact free cash flow: 114381000 USD 2003-01-01 – 2003-12-31: 157000000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 42619000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 2003-12-31 ALPHARMA INC (edgar:730469) Free cash flow: 114381000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 157000000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6154 Input fundies:CapitalExpenditure: 42619000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-05-000003.txt#6183 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 314.74 million Exact value Exact value: -314737000 USD 2004-01-01 – 2004-12-31: -314737000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 2004-12-31 ALPHARMA INC (edgar:730469) Net Income: -314737000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -314737000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-07-000017.txt#5250 The citation records this snapshot. The page link may show a newer release later.	USD 186.16 million Exact value Exact value: 186162000 USD 2004-01-01 – 2004-12-31: 186162000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 2004-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 186162000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 186162000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-07-000017.txt#5449 The citation records this snapshot. The page link may show a newer release later.	USD 49.31 million Exact value Exact value: 49306000 USD 2004-01-01 – 2004-12-31: 49306000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 2004-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 49306000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 49306000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-07-000017.txt#5475 The citation records this snapshot. The page link may show a newer release later.	USD 136.86 million Calculation and evidence 186162000 − 49306000 USD Exact free cash flow: 136856000 USD 2004-01-01 – 2004-12-31: 186162000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 49306000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 2004-12-31 ALPHARMA INC (edgar:730469) Free cash flow: 136856000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 186162000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-07-000017.txt#5449 Input fundies:CapitalExpenditure: 49306000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-07-000017.txt#5475 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 133.77 million Exact value Exact value: 133769000 USD 2005-01-01 – 2005-12-31: 133769000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 2005-12-31 ALPHARMA INC (edgar:730469) Net Income: 133769000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 133769000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5432 The citation records this snapshot. The page link may show a newer release later.	USD 247.28 million Exact value Exact value: 247281000 USD 2005-01-01 – 2005-12-31: 247281000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 2005-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 247281000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 247281000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5671 The citation records this snapshot. The page link may show a newer release later.	USD 38.94 million Exact value Exact value: 38939000 USD 2005-01-01 – 2005-12-31: 38939000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 2005-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 38939000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 38939000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5710 The citation records this snapshot. The page link may show a newer release later.	USD 208.34 million Calculation and evidence 247281000 − 38939000 USD Exact free cash flow: 208342000 USD 2005-01-01 – 2005-12-31: 247281000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 38939000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 2005-12-31 ALPHARMA INC (edgar:730469) Free cash flow: 208342000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 247281000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5671 Input fundies:CapitalExpenditure: 38939000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5710 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 82.54 million Exact value Exact value: 82544000 USD 2006-01-01 – 2006-12-31: 82544000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 2006-12-31 ALPHARMA INC (edgar:730469) Net Income: 82544000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 82544000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5432 The citation records this snapshot. The page link may show a newer release later.	USD 42.93 million Exact value Exact value: 42933000 USD 2006-01-01 – 2006-12-31: 42933000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 2006-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 42933000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 42933000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5671 The citation records this snapshot. The page link may show a newer release later.	USD 36.17 million Exact value Exact value: 36171000 USD 2006-01-01 – 2006-12-31: 36171000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 2006-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 36171000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36171000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5710 The citation records this snapshot. The page link may show a newer release later.	USD 6.76 million Calculation and evidence 42933000 − 36171000 USD Exact free cash flow: 6762000 USD 2006-01-01 – 2006-12-31: 42933000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 36171000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 2006-12-31 ALPHARMA INC (edgar:730469) Free cash flow: 6762000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 42933000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5671 Input fundies:CapitalExpenditure: 36171000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5710 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 13.58 million Exact value Exact value: -13581000 USD 2007-01-01 – 2007-12-31: -13581000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALPHARMA INC · 2007-12-31 ALPHARMA INC (edgar:730469) Net Income: -13581000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13581000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5432 The citation records this snapshot. The page link may show a newer release later.	USD 46.99 million Exact value Exact value: 46991000 USD 2007-01-01 – 2007-12-31: 46991000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALPHARMA INC · 2007-12-31 ALPHARMA INC (edgar:730469) Operating Cash Flow: 46991000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 46991000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5671 The citation records this snapshot. The page link may show a newer release later.	USD 60.5 million Exact value Exact value: 60499000 USD 2007-01-01 – 2007-12-31: 60499000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALPHARMA INC · 2007-12-31 ALPHARMA INC (edgar:730469) Capital Expenditure: 60499000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 60499000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5710 The citation records this snapshot. The page link may show a newer release later.	−USD 13.51 million Calculation and evidence 46991000 − 60499000 USD Exact free cash flow: -13508000 USD 2007-01-01 – 2007-12-31: 46991000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 60499000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALPHARMA INC · 2007-12-31 ALPHARMA INC (edgar:730469) Free cash flow: -13508000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:33:14Z Snapshot: 5c89a215d6efd741b1911402a38feb5f33812dfdf29ad33f715e989a5f487a64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/730469?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 46991000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5671 Input fundies:CapitalExpenditure: 60499000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/730469/0000730469-08-000102.txt#5710 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

97 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000730469, 730469, edgar:730469

Also known as A L LABORATORIES INC, A L PHARMA INC

ALPHARMA INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation